Skip to content
No picture yet

Ayvakyt 25 mg – DIN 02551764

Ayvakyt is Avapritinib 25 mg (tablet), sold in Canada. It is used for gastrointestinal stromal tumors. It is supplied by Blueprint Medicines Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Avapritinib 25 mg

Brand
Ayvakyt
Strength
25 mg
Used for
Gastrointestinal stromal tumors
Form
Tablet
Manufacturer
Blueprint Medicines Corporation
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02551764

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Avapritinib pills and guides

What is Avapritinib used for?

Avapritinib is used for gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

PDGFRA Exon 18 Mutation-Positive Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

AYVAKIT® is indicated for the treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.

Advanced Systemic Mastocytosis (AdvSM)

AYVAKIT is indicated for the treatment of adult patients with advanced systemic mastocytosis (AdvSM). AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).

Limitations of Use:

AYVAKIT is not recommended for the treatment of patients with AdvSM with platelet counts of less than 50 × 109/L.

Indolent Systemic Mastocytosis (ISM)

AYVAKIT is indicated for the treatment of adult patients with indolent systemic mastocytosis (ISM).

Limitations of Use:

AYVAKIT is not recommended for the treatment of patients with ISM with platelet counts of less than 50 × 109/L.

From the FDA-approved label on DailyMed (published Sep 18, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02551764.
  • It names Ayvakyt, Avapritinib 25 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Ayvakyt by Blueprint Medicines Corporation.

In Canada: prescription only.

Ingredients

Active: Avapritinib

Other Avapritinib pills